TrialBlood advances2020

Morphologic remission status is limited compared to ΔN flow cytometry: a Children's Oncology Group AAML0531 report.

Lisa Eidenschink Brodersen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.